Home
[an error occurred while processing this directive]
Quality survey Health benefits Safety Reading labels Ask the supplier Standards & regulations



Editorials





Testing news
Search
Links
Glossary
Glossary
Ask the expert
Bookstore
Sponsorship
Contact us
Disclaimer
Privacy policy
Sponsorship
 

Headline News

Misbranded Dietary Supplements Destroyed
College Park MD, 5 May 2003

The Food and Drug Administration (FDA) announced today that Nature's Youth, LLC, of Centerville MA has completed its voluntary destruction of approximately 5700 boxes (each containing a 30-day supply) of its misbranded product, "Nature's Youth hGH." This destruction, which occurred at locations in Massachusetts and Florida, was recently completed and involved approximately $515,000 worth of product. The firm also indicated it would change the labeling for future marketing of the product in order to comply with the law.

"FDA is committed to help consumers make health and dietary choices based on accurate information," said FDA Commissioner Mark McClellan, MD,PhD. "FDA will continue to take strong action to protect American consumers from dietary supplements that are not accurately labeled or that make misleading claims unsupported by scientific evidence."

FDA determined the product was misbranded after evaluating unsubstantiated "structure and function" claims made on the company's website, as well as a review of the labeling of the product line. Among the false and misleading claims was that Nature's Youth hGH was a "proprietary blend of amino acids and precursor nutrients which enhance the body's natural production of Human Growth Factors and Insulin-like Growth Factor-1" that would, among other things, "improve physical performance, speed recovery from training, increase cardiac output, and increase immune functions." The product also claimed to be "your body's best defense against aging."

In this case, the company claimed that an article in the New England Journal of Medicine (Volume 323:1-6, Number 1, 5 July 1990) provided substantiation for their claim. However, the New England Journal of Medicine (Volume 348:777-778, Number 9, 27 February 2003) included a clear statement that such a claim was misleading. The editor-in-chief wrote in part, "If people are induced to buy a 'human growth hormone releaser' on the basis of research published in the Journal, they are being misled."

FDA will continue to monitor the marketplace to ensure that products purporting to be dietary supplements are labeled properly and that claims being made for these types of products are not false or misleading.

Source

US Food and Drug Administration (FDA).end-of-story

 

 

 

   
[an error occurred while processing this directive]
Health benefits Safety Reading labels Ask the supplier Standards & regulations Contact us

(c) Copyright 1999-2003 Dietary Supplement Quality Initiative. For permission to reprint, please contact our editor.